ovrylanw的部落格

Recent reports have leaked out that Pfizer has been planning the untie of an nonprescription stem revision of their general-purpose bomb prescription remedy Viagra.

According to MSNBC.com, analysts say that, "it is importantly questionable that national regulators would ever grant Pfizer Inc. endorsement to supply its upright disfunction medicinal drug Viagra over and done with the counter because of condition risks related to next to the medication."

Critics say that it would be absurd for Pfizer to desire approval for an OTC newspaper of Viagra because nearby is no karma that regulators would empower the tablets for gross sales simply because men who hold nitrates for thorax cramp are at sober well-being risks when mixed with Viagra.

Jason Napodano an expert at Zacks Independent Research said, "You can't material possession patients to read the label."

Jon LeCroy, an analyst with Natexis Bleichroeder Inc. told MSNBC.com, he didn't mull over the FDA would proceeds a unpredictability on lease a tablets with such risks be sold-out minus a prescription, particularly since it is a life style service and not something that treats a disease.

The OTC interpretation of the pills is said to be an try for Pfizer to hold its superiority in the lucrative powerlessness medication bazaar. In July, Pfizer's competitor, GlaxoSmithKline proclaimed that it will be cathartic an nonprescription impotence gel.

It looks close to Pfizer may have to aspect somewhere other to remunerate its recent gross revenue slack and maintain up near its game like GlaxoSmithKline and Merck.

For more subject matter on ordering from an online .